Chris Miller

He is a pioneer in nitric oxide technology and therapeutic research.

He is a co-founder and CEO/CSO experience in nitric oxide biotech startup fundraising and out licensing. He has 20 years of expertise in design & execution of clinical trials, 20 years of experience in Intellectual Property, regulatory and management. He is a Retired Assistant Professor in the Faculty of Medicine, Respiratory & Infectious Diseases Divisions, University of British Columbia, Canada.

He holds a PhD in Experimental Medicine and degrees in Health Management and Respiratory Therapy.